Lupin Pharma Canada announces the availability of Intrarosa® (prasterone vaginal ovules), a new treatment option in Canada for women with postmenopausal vulvovaginal atrophy
/CNW Telbec/ - Lupin Pharma Canada, a wholly-owned subsidiary of Lupin Limited (Lupin), announced today the launch of Intrarosa® (prasterone vaginal ovules)...